Rapport Therapeutics, Inc. SEC filings RAPP
Rapport Therapeutics, Inc. has 253 filings in SEC EDGAR's recent list, going back to Mar 27, 2024. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 305B2 | Filing | Oct 29, 2026 | — |
| EFFECT | Filing | Jul 9, 2025 | — |
| EFFECT | Filing | Jul 9, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2025 | — |
| SEC STAFF LETTER | Filing | Jul 26, 2024 | — |
| EFFECT | Filing | Jun 6, 2024 | — |
| CERT | Filing | Jun 6, 2024 | — |
| 8-A12B | Filing | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 4, 2024 | — |
| CORRESP | Letter to the SEC | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| UPLOAD | Letter from the SEC | May 13, 2024 | — |
| SEC STAFF LETTER | Filing | May 3, 2024 | — |
| DRSLTR | Filing | Apr 29, 2024 | — |
| DRS/A | Filing | Apr 29, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2024 | — |
| DRS | Filing | Mar 27, 2024 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RAPP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2012593
- Former names
- Rapport Therapeutics, Inc. (until Nov 4, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.